MedTrace Logo

Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate

NCT00999297 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2015-11-20

No results posted yet for this study

Summary

A 4 week intake of drug to find a natural substance that may modify energy balance and may enhance health in combination with lifestyle changes with possible decrease in body weight.

Conditions

Interventions

OTHER

Dihydrocapsiate

Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo

OTHER

Dihydrocapsiate

Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo

OTHER

Dihydrocapsiate

Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo

Sponsors & Collaborators

  • Ajinomoto USA, INC.

    collaborator INDUSTRY

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Eric Ravussin, PhD · Pennington Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-11-30
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00999297 on ClinicalTrials.gov